ABVC vs ACHV

ABVC Biopharma, Inc. vs Achieve Life Sciences, Inc. — Valuation Comparison 2026

ABVC

Biotechnology
ABVC Biopharma, Inc.
Quality
4.9
out of 10
Value Trap
24
SAFE
Price
$1.41
Last close
Models
8/13
Active
VS

ACHV

Biotechnology
Achieve Life Sciences, Inc.
Quality
4.3
out of 10
Value Trap
30
LOW
Price
$5.24
Last close
Models
7/13
Active

Model-by-Model Comparison

ModelType ABVC Fair ValueABVC Upside ACHV Fair ValueACHV Upside
Bayesian DCF Intrinsic $0.31 -78.3% $1.55 -70.4%
EROIC Spread Intrinsic $•••.•• ••.•% $•••.•• ••.•%
First Chicago Scenario $•••.•• ••.•% $•••.•• ••.•%
ML-RIV Intrinsic $•••.•• ••.•% $•••.•• ••.•%
Dynamic NAV Asset-Based $0.08 -94.4% $0.41 -92.2%
PWERM Option-Based $•••.•• ••.•% $•••.•• ••.•%
Sentiment SOTP Hybrid $•••.•• ••.•% $•••.•• ••.•%
CUCE Ensemble Ensemble $•••.•• ••.•% $•••.•• ••.•%
FTNN Topology Relative $•••.•• ••.•% $•••.•• ••.•%
RCMH-DCF Intrinsic $•••.•• ••.•% $•••.•• ••.•%
🔒

Unlock Full 13-Model Comparison

Access all valuation models for ABVC vs ACHV — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

ABVC vs ACHV — Which Stock Is More Undervalued?

ABVC scores higher with a 4.9/10 quality rating vs ACHV's 4.3/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing ABVC Biopharma, Inc. (ABVC) and Achieve Life Sciences, Inc. (ACHV) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

ABVC currently trades at $1.41 with a QOC of 4.9/10, while ACHV trades at $5.24 with a QOC of 4.3/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).